U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.1615CTT[1] (p.Leu540del) AND Lynch syndrome

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Oct 18, 2018
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000515764.8

Allele description [Variation Report for NM_000179.3(MSH6):c.1615CTT[1] (p.Leu540del)]

NM_000179.3(MSH6):c.1615CTT[1] (p.Leu540del)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.1615CTT[1] (p.Leu540del)
HGVS:
  • NC_000002.11:g.48026740_48026742del
  • NC_000002.12:g.47799598CTT[1]
  • NG_007111.1:g.21452CTT[1]
  • NM_000179.3:c.1615CTT[1]MANE SELECT
  • NM_001281492.2:c.1225CTT[1]
  • NM_001281493.2:c.709CTT[1]
  • NM_001281494.2:c.709CTT[1]
  • NP_000170.1:p.Leu540del
  • NP_001268421.1:p.Leu410del
  • NP_001268422.1:p.Leu238del
  • NP_001268423.1:p.Leu238del
  • LRG_219:g.21452CTT[1]
  • NC_000002.11:g.48026736_48026738del
  • NC_000002.11:g.48026737CTT[1]
  • NC_000002.11:g.48026740_48026742del
  • NM_000179.2:c.1618_1620delCTT
  • NM_000179.3:c.1618_1620delMANE SELECT
Protein change:
L238del
Links:
dbSNP: rs1064793600
NCBI 1000 Genomes Browser:
rs1064793600
Molecular consequence:
  • NM_000179.3:c.1615CTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001281492.2:c.1225CTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001281493.2:c.709CTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
  • NM_001281494.2:c.709CTT[1] - inframe_deletion - [Sequence Ontology: SO:0001822]
Observations:
1

Condition(s)

Name:
Lynch syndrome
Identifiers:
MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000611879University of Washington Department of Laboratory Medicine, University of Washington
criteria provided, single submitter

(Tsai GJ et al. (Genet Med 2018))
Pathogenic
(Mar 28, 2018)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

SCV000920456International Society for Gastrointestinal Hereditary Tumours (InSiGHT)
reviewed by expert panel

(Guidelines v2.4)
Pathogenic
(Oct 18, 2018)
germlinecuration

Citation Link,

SCV004834317All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Pathogenic
(Dec 18, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided108544not providedclinical testing
not providedgermlinenonot provided1not providednot providedyesresearch
not providedgermlineyesnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.

Tsai GJ, Rañola JMO, Smith C, Garrett LT, Bergquist T, Casadei S, Bowen DJ, Shirts BH.

Genet Med. 2019 Jun;21(6):1435-1442. doi: 10.1038/s41436-018-0335-7. Epub 2018 Oct 30.

PubMed [citation]
PMID:
30374176

Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals.

Dámaso E, González-Acosta M, Vargas-Parra G, Navarro M, Balmaña J, Ramon Y Cajal T, Tuset N, Thompson BA, Marín F, Fernández A, Gómez C, Velasco À, Solanes A, Iglesias S, Urgel G, López C, Del Valle J, Campos O, Santacana M, Matias-Guiu X, Lázaro C, Valle L, et al.

Cancers (Basel). 2020 Jul 5;12(7). doi:pii: E1799. 10.3390/cancers12071799.

PubMed [citation]
PMID:
32635641
PMCID:
PMC7408773
See all PubMed Citations (4)

Details of each submission

From University of Washington Department of Laboratory Medicine, University of Washington, SCV000611879.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedyesresearch PubMed (1)

Description

The MSH6 variant designated as NM_000179.2:c.1618_1620del (p.Leu540del) is classified as pathogenic. Cosegregation analysis of one observed family was performed using analyze.myvariant.org (Rañola et al, 2018, PMID:28965303) and gives a likelihood of 1.838 to 1, which supports pathogenicity (Thompson et al, 2003, PMID:12900794). In addition, endometrial and colorectal tumors from an affected individual in the family contained the germline MHS6 p.Leu540del variant. Each tumor had microsatellite instability and had a different independent second heterozygous pathogenic mutation in MSH6. Each of these observations supports classification of pathogenicity. In addition, this variant has previously been reported in two MSI high tumors with lack of MSH6 staining on IHC (http://www.umd.be/). Bayesian analysis integrating all of this data (Tavtigian et al, 2018, PMID:29300386) gives over 99% probability of pathogenicity, which is consistent with a classification of pathogenic. This variant is predicted to alter MSH6 function and increase cancer risk. This reclassification analysis was performed in conjunction with the family studies project as part of the University of Washington Find My Variant Study.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot provided1not provided

From International Society for Gastrointestinal Hereditary Tumours (InSiGHT), SCV000920456.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

Multifactorial likelihood analysis posterior probability > 0.99 (0.992)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004834317.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (3)

Description

This variant causes a deletion of one amino acid in exon 4 of the MSH6 protein. This variant has been observed in several individual affected with Lynch sydrome-associated cancer (PMID: 32635641; ClinVar SCV000580277.5), with tumors that exhibited microsatellite instability and/or loss of MSH6 proteins by immunohistochemistry analyses. RNA analysis demonstrated the presence of an aberrant transcript at low proportion alongside the full-length transcript (PMID: 32635641). This variant has also been observed in homozygous state in individuals affected with autosomal recessive constitutional mismatch mismatch repair deficiency (PMID: 34787334; ClinVar SCV000813105.5). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

Last Updated: Aug 11, 2024